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The Centers for Disease Control and Prevention (CDC) is the nation’s health protection agency. As part of the 
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, the Division of HIV/AIDS 
Prevention (DHAP) promotes health and quality of life by preventing HIV infection and reducing HIV-related 
illness and death in the United States. This CDC National HIV Prevention Progress Report describes progress 
toward achieving the goals and objectives of the DHAP Strategic Plan for 2011-2015. It uses data from CDC HIV 
surveillance systems to report on 21 indicators that support planning, monitoring, and improvement related to 
three key priorities of the National HIV/AIDS Strategy (NHAS): 
•	 Reducing new HIV infections
•	 Increasing access to care and improving health outcomes for people living with HIV
•	 Reducing HIV-related health disparities
This report provides an overview of trends before the DHAP Strategic Plan for 2011-2015 was put in place, and, 
where data are available, presents results for the first year of the Strategic Plan’s implementation. Progress toward 
achieving the 2015 goals is evaluated against annual targets. These targets are based on the assumption that large-
scale programmatic change takes time. They also reflect the expectation that more improvement will occur over 
time as these changes are more fully implemented. Goals, objectives, and annual targets may be revised based on 
funding levels as well as scientific and programmatic advances. 
CDC is committed to improving transparency and accountability. This CDC National HIV Prevention Progress 
Report reflects that commitment. Some of the indicators in this report are also used to monitor and report 
results for a number of important federal efforts including the NHAS, Healthy People 2020, the Government 
Performance and Results Act (GPRA), and the Department of Health and Human Service’s Core HIV Indicators.
The results show some encouraging signs of progress, but they also draw attention to areas where more 
improvement is needed. The Progress At-A-Glance summarizes the most recent results described in this 
report. This report shows that:
•	 The annual targets were met or exceeded for 13 of the 21 indicators (62%). These indicators include 
the HIV transmission rate and knowledge of HIV-positive status.
•	 There was no change or movement away from the annual target for 5 of the 21 indicators (24%). 
These indicators include sexual risk behaviors among gay, bisexual, and other men who have sex 
with men (collectively referred to as MSM); new infections among MSM and Hispanics/Latinos; 
and linkage to HIV medical care among blacks/African Americans and Hispanics/Latinos.
•	 Progress could not be fully assessed for 3 of the 21 indicators (14%) that did not have data available 
for the annual target year but will have data available in future years.
The report highlights differences by gender, age, race/ethnicity, and HIV transmission risk. Making progress 
among those who are disproportionately affected by HIV is especially important for achieving national goals and 
improving health equity. 
Achieving all of the nation’s HIV prevention goals will not be easy and is dependent upon progress in groups that 
are disproportionately affected and progress made at the local level. Many programs may have to adopt new and 
more cost-effective strategies in order to realize the benefits of a high-impact approach to HIV prevention. The 
response of federal, state, and local agencies; health care providers; and community-based organizations should 
keep pace with the needs of a growing number of people living with HIV and those who are at greatest risk in 
order to achieve the 2015 goals.
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Progress at-a-glanCe 












ns Reduce new HIV infections by 25% 36,450 48,600 47,500 
Increase knowledge of HIV-positive status to 90% 90.0% 80.9% 84.2% 
Reduce late stage HIV diagnosis by 25% 19.1% 25.1% 24.9% 
Reduce the perinatal HIV transmission rate by 25% 5.1 6.8 5.7 
Reduce sexual risk behavior among MSM by 25% 10.3% 13.5% 13.7% 























es Reduce the HIV transmission rate by 30% 3.2 4.6 4.2 
Increase linkage to HIV medical care to 85% 85.0% 66.0% 79.8% 
Increase viral suppression among persons in HIV medical care by 10% 78.8% N/A 71.6% 



















Reduce new HIV infections among groups at increased risk by at least 25%
— MSM 21,675 28,900 31,400
— IDUs 3,975 5,300 3,900
— Blacks/African Americans 15,900 21,200 20,900
— Hispanics/Latinos 6,750 9,000  9,800
Increase linkage to HIV medical care among all racial/ethnic groups to 85% or greater (goal changed from 75% to 85%)*
— Blacks/African Americans 85.0% 77.3% 75.9%
— Hispanics/Latinos 85.0% 83.2% 81.8%
— Whites 85.0% 83.6% 85.1%
— Persons of other races/ethnicities 85.0% 85.0% 85.9%
Increase viral suppression among specific groups by at least 20%
— HIV-diagnosed MSM 48.8% 40.7% 41.7%
— HIV-diagnosed Blacks/African Americans 39.2% 32.7% 34.9%
— HIV-diagnosed Hispanics/Latinos 43.9% 36.6% 37.2%




Not met—no change or moved 
away from annual target
Data not available
for target year
Annual Targets and Results represent the most currently available data. See Indicator Summaries and on-line Technical Notes for baseline, 
target, and result years and additional information.
*For linkage to HIV medical care among all racial/ethnic groups, the 2015 goal was increased from 75% or greater to 85% or greater. 
† This symbol did not apply to any indicator in this year’s report. It is presented here because it may apply to indicator data in future years.
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introduCtion
We’ve made significant progress, but our fight against HIV is far from over. More than three decades have 
passed since the first AIDS cases were reported in the United States. Since then we’ve made tremendous advances 
in the detection, prevention, and treatment of HIV. Scientific advances, such as new HIV testing technologies, 
pre-exposure prophylaxis (PrEP), and treatment as prevention have given us important new tools that have the 
potential to dramatically slow the further spread of HIV here and abroad.
Despite this progress, we continue to face major challenges. In the United States, more than 1.1 million people 
are living with HIV, and about 50,000 more become infected each year. About 1 in 6 people living with HIV do 
not know that they have the virus. Too many people die from HIV infection each year, and many more are not 
getting the medical care and treatment they need. Racial and ethnic disparities persist, and gay, bisexual, and 
other men who have sex with men (collectively referred to as MSM) still account for the largest number of new 
HIV infections. At the same time, many states, cities, and community-based organizations have had to do more 
with fewer resources.
The National HIV/AIDS Strategy (NHAS), released by the White House in July 2010, represents the nation’s 
first-ever comprehensive federal plan to respond to HIV in the United States. The NHAS sets three broad 
goals for the nation—reducing new HIV infections; increasing access to care and improving health outcomes 
for people living with HIV; and reducing HIV-related health disparities. It calls for the nation to build on our 
successes in HIV prevention, care, and treatment, and it recognizes the need to refocus existing efforts in order 
to deliver better results. 
The Centers for Disease Control and Prevention (CDC) is the nation’s health protection agency. As part of 
the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, the Division of HIV/AIDS 
Prevention (DHAP) promotes health and quality of life by preventing HIV infection and reducing HIV-related 
illness and death in the United States. The DHAP Strategic Plan for 2011-2015 supports the goals of the NHAS 
and provides a road map for CDC’s response to domestic HIV. CDC’s response includes supporting prevention 
programs, raising HIV awareness, tracking the HIV epidemic, and supporting prevention research. These 
activities are guided by CDC’s High-Impact Prevention approach that ensures CDC is best allocating its limited 
resources and maximizing the effects of its and its partners’ prevention efforts.
This CDC National HIV Prevention Progress Report describes progress toward achieving key CDC goals 
and objectives. It provides an overview of trends before the current DHAP Strategic Plan was implemented 
and, where data are available, presents results for the first year of the strategic plan. Progress toward achieving 
2015 goals is evaluated against annual targets. These targets are based on the assumption that large-scale 
programmatic change takes time. They also reflect the expectation that more improvement will occur over time 
as these changes are more fully implemented. Goals, objectives, and annual targets may be revised based on 
funding levels as well as scientific and programmatic advances. This report is not intended to evaluate progress 
on the NHAS. The Office of National AIDS Policy has issued a separate report on the NHAS.
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CDC’s Approach to HIV Prevention
CDC’s response to HIV is based on its High-Impact HIV Prevention approach for targeting the most cost-
effective and scalable interventions and aligning them geographically and demographically with the burden of 
HIV. The approach is designed to maximize the impact of federal prevention dollars and further our collective 
progress toward achieving the goals of the NHAS.
CDC works with partners in other federal, state, and local agencies as well as national, regional, and 
community-based organizations to support proven strategies that can reduce the risk of acquiring or 
transmitting HIV and improve the health of people living with HIV.
More information about CDC’s domestic HIV prevention activities can be found in the DHAP Annual Report or 
online at www.cdc.gov/hiv.
Measuring Progress
The twenty-one indicators in this report 
provide an objective way to assess progress 
toward achieving key HIV prevention goals. 
They also provide feedback that guides CDC 
planning and program improvement activities. 
CDC is committed to improving health 
equity and, whenever possible, CDC monitors 
progress on these indicators by gender, age, 
race/ethnicity, and HIV transmission risk. In 
addition, 11 indicators focus specifically on 
HIV-related disparities.
The data for these indicators come from three 
CDC HIV surveillance systems—the National 
HIV Surveillance System (NHSS), the Medical 
Monitoring Project (MMP), and the National 
HIV Behavioral Surveillance System (NHBS). 
The accurate and timely reporting and use 
of indicator data is a priority for CDC. 
Producing high-quality data takes time. The 
data are collected by local jurisdictions that, 
depending on the system, rely on reporting 
from doctors’ offices and laboratories as well 
as medical record abstractions, in-person 
interviews, and death records. Incomplete or 
duplicate information is often received and 
requires additional follow-up before the data 
can be considered complete and ready for 
public dissemination. CDC is actively working 
to improve the timeliness of these data.
CDC HIV Surveillance Systems— 
Data Sources for Indicators
National HIV Surveillance System (NHSS)
HIV Case Surveillance: All 50 states, the District of Columbia, and 6 US 
dependent areas report confirmed diagnoses of HIV and AIDS to CDC including 
demographic characteristics, transmission category, and initial immune status. 
For 2011 data, 19 jurisdictions had reported to CDC all CD4 and HIV viral load 
test results for January 2009 through December 2011.
HIV Incidence Surveillance: CDC uses data on HIV testing and antiretroviral 
use history, as well as results from the serologic testing algorithm for recent 
HIV seroconversion (STARHS) methodology, to generate annual estimates of the 
number of new HIV infections. Since 2008, 25 jurisdictions have been funded 
to conduct incidence surveillance. Using a complex statistical model, CDC 
extrapolates data from these 25 jurisdictions to yield a national estimate for the 50 
states and the District of Columbia.
Medical Monitoring Project (MMP)
MMP uses a three-stage sampling approach that is designed to produce nationally 
representative information about adults receiving HIV medical care in the US. Data 
are collected for samples of patients at outpatient HIV medical care facilities. Since 
2009, 16 states, 6 cities, and Puerto Rico have been funded to participate. 
National HIV Behavioral Surveillance System (NHBS)
NHBS conducts behavioral surveillance in rotating three-year cycles among three 
populations at high risk for HIV infection— MSM, injection drug users, and 
heterosexuals at increased risk for HIV infection. Data are collected in US cities with 
a high burden of AIDS. As of 2011, 20 cities have been funded to conduct NHBS. 
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This report evaluates progress compared to annual targets. Targets are based on the assumption that 
change will occur over time and will accelerate with each passing year. For each indicator, a baseline year 
was identified as the starting point for setting annual targets. The baseline years and 2015 goals established by 
the NHAS were adopted for the 7 objectives that come from the NHAS. 
The annual target for 2010 is the same as the baseline year; this assumes stability prior to the implementation 
of the DHAP Strategic Plan. In setting targets for other years, it was expected that greater improvement would 
occur in future years as programmatic changes are more fully implemented. The following assumptions were 
used to measure annual progress toward 2015 goals: 5% of the total change would occur in 2011, 15% in 2012, 
20% in 2013, 30% in 2014, and 30% in 2015. These annual targets take into account the time needed for program 
planning, start-up activities, and for effects of these changes to be seen in the data. Over time, goals, objectives, 
and annual targets may be updated as revised estimates become available so that these indicators represent the 
most accurate data at the time the report is published. 
This report assesses whether annual targets have been met and whether there has been progress toward the 
2015 goals. It does not use statistical tests to assess changes over time, differences between groups, or differences 
between the result and the target. This report is intended to provide a qualitative overview of where there has been 
movement toward the 2015 goal and where additional progress is needed. Statistically significant change is not 
expected from each year to the next and may not always be necessary to achieve the 2015 goal. Additional data for 
some indicators are available in other publications and may include information about statistical significance.
This report describes annual progress toward 2015 goals and objectives. For each objective, a symbol is 
assigned to denote if the annual target was:  
Met or exceeded       
Not met but available data show improvement* 
Not met and available data show no change or movement away from the target      
Not able to be assessed because data are not available for the target year
* This symbol did not apply to any indicator in this year’s report. It is presented here because it may apply to indicator data in future years.
7
Many of these are part of other federal performance-related monitoring and reporting activities. This report identifies 
the monitoring and reporting activities that each indicator is used for. These are noted in the indicator summaries 
with the following symbols:
National HIV/AIDS Strategy—a comprehensive national HIV/AIDS 
plan with clear and measurable targets to be achieved by 2015
Government Performance and Results Act (GPRA)—holds federal 
agencies accountable for achieving results through goal setting and 
performance measurement. Results are reported with the President’s 
annual budget request.
Healthy People 2020 (HP 2020)—science-based, national objectives 
for improving the health of all Americans and measuring the impact of 
prevention activities
Department of Health and Human Services (HHS) Core HIV 
Indicators—seven core indicators for monitoring HHS-funded HIV 
prevention, treatment, and care services
Looking Forward 
CDC’s HIV prevention efforts in the United States support the NHAS and are guided by the DHAP Strategic Plan for 
2011-2015. However, achieving all of the nation’s HIV prevention goals will not be easy.
•	 Fully implementing High-Impact Prevention will take time and may require that many CDC-funded agencies 
make substantial changes in the planning and implementation of HIV prevention programs in order to have 
the greatest possible impact using the most cost-effective prevention strategies.
•	 Decreased funding for HIV programs experienced by many state and local governments and community-based 
organizations may have an adverse effect on their ability to provide high quality HIV prevention services to 
those who are at risk for HIV infection. 
•	 Effective HIV treatment has made it possible for more people with HIV to live longer, healthier lives. This is a 
positive result of important advances in HIV testing, medical care, and treatment. It also means there are more 
people living with HIV in need of prevention services, HIV medical care, and treatment. 
The indicators in the CDC National HIV Prevention Progress Report provide an important opportunity to reflect 
on our collective progress—where we’ve been successful, and where we need to do better. In order to overcome the 





REDUCE NEW HIV INFECTIONS
Reduce the annual number of new HIV infections by 25%
Reducing the number of new HIV 
infections is DHAP’s number one 
priority. Too many people get HIV each 
year in the United States. HIV infection 
has many costs to individuals, families, 
and communities. 
There were slightly fewer new HIV 
infections in 2010 compared to 2006, 
and the 2010 target (48,600) was 
met. However, the number of new HIV 
infections remains unacceptably high.
CDC compared data for 2008 and 2010 
for key subgroups and found that the 
overall stability in the number of new 
infections masks important underlying 
trends. For example, new HIV infections 
decreased 21% among women (data 
not shown) and were stable or decreased in all transmission risk groups except gay, 
bisexual, and other men who have sex with men (collectively referred to as MSM).
High-Impact Prevention, emphasizing proven, cost-effective and scalable 
interventions, will be needed to achieve the 2015 goal.
Data Source: National HIV Surveillance System (NHSS). See references and on-line Technical Notes 
for additional information.
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New HIV Infections by Transmission Risk
•	 More HIV infections occur among MSM 
than any other risk group. 
•	 Comparing 2008 to 2010, HIV infections 
attributed to heterosexual transmission 
decreased 15% and new infections 
attributed to injection drug use decreased 
22%.
•	 During this time, HIV infections increased 
12% among MSM overall and 22%  
among young MSM aged 13-24 years.  
[data not shown]
•	 It will be necessary to reduce HIV 
infections among MSM to achieve the 2015 
goal.
New HIV Infections by Race/Ethnicity
•	 More HIV infections occur among blacks/
African Americans than any other racial/
ethnic group. 
•	 Comparing 2008 to 2010, new HIV 
infections were stable for all race/ethnicity 
groups. There was, however, a 21% reduction 
in new HIV infections among black/African 
American females. [data not shown]
•	 In order to achieve the 2015 goal, reductions 
in new HIV infections are needed across 
racial/ethnic groups, especially blacks/
African Americans.
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INCREASE KNOWLEDGE OF HIV+ STATUS
Increase the percentage of people living with HIV who know their serostatus to 90%
People living with HIV need to know 
their HIV status in order to get the 
right medical care, protect their 
health, and reduce HIV transmission 
to others. HIV testing efforts have 
succeeded in reducing the number  
of persons with undiagnosed  
HIV infection. 
From 2006 to 2010, the percentage of 
people living with HIV who had been 
diagnosed (and who are assumed for 
this indicator to know their serostatus) 
increased from 80.9% to 84.2%. 
This means that 5 of 6 people living 
with HIV in 2010 knew their status. 
Consistent improvement was seen 
from year to year, and the 2010 target 
(80.9%) was exceeded.
But there is more to be done. About 180,000 people in the U.S. are living with 
undiagnosed HIV  infection. Each new infection will be harder to find as the 
number of people with undiagnosed HIV decreases. In order to achieve the 
2015 goal, testing efforts will need to reach more people with undiagnosed 
infection through a combination of routine HIV screening and targeted HIV 
testing in clinical and community settings. 
Fewer People have Undiagnosed HIV Infection
•	 Almost 1 million people living with HIV 
had been diagnosed as of 2010. 
•	 The total number of people living with 
HIV (HIV prevalence) increased 9% from 
1,045,800 in 2006 to 1,144,500 in 2010. 
•	 Even though HIV prevalence increased, the 
number of people with undiagnosed HIV 
infection decreased 9% from 199,748 in 
2006 to 180,900 in 2010. 
Data Source: National HIV Surveillance System (NHSS).  
See references and on-line Technical Notes for  
additional information.
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Knowledge of HIV-Positive Status by Transmission Risk 
•	 Diagnosed HIV infection among people living 
with HIV remained fairly stable or improved 
slightly in most transmission risk groups from 
2006 to 2010. For heterosexual males, the 
percentage of people living with HIV whose 
infection had been diagnosed increased 12% 
from 2006 to 2010.
•	 The 2015 goal was exceeded in 2009 and  
2010 for male and female injection drug  
users (IDUs).
•	 The greatest improvement is needed among 
gay, bisexual, and other men who have sex 
with men (collectively referred to as MSM), 
heterosexual males, and heterosexual females.
Knowledge of HIV-Positive Status by Age
•	 The overall improvement in diagnosis of 
HIV-positive status has been driven by gains 
in older age groups. In 2010, the 2015 goal had 
been met for people aged 45 years and older.
•	 Young people aged 13-24 years living with 
HIV are least likely to have had their infection 
diagnosed. The percentage of those who had 
been diagnosed declined 8% in this group from 
2006 to 2010. Young people may have been 
infected more recently and have had less time 
to be tested and diagnosed compared to  
older adults.
•	 In order to achieve the 2015 goal, it will be 
especially important to increase knowledge  
of HIV status among people under 35 years  
of age. 
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REDUCE LATE STAGE HIV DIAGNOSIS
Reduce the percentage of people with a diagnosis of stage-3 HIV infection (AIDS) within 3 
months after HIV diagnosis by 25%
Early diagnosis improves the health 
and survival of people with HIV and 
reduces HIV transmission. People 
who are diagnosed with HIV infection 
at an advanced stage of disease have 
most likely been infected for many 
years. This represents multiple missed 
opportunities to diagnose and treat the 
infection and to prevent transmission 
to others.
The 2011 target (25.1%) was met, 
reflecting modest progress in 
decreasing the percentage of persons 
with a late diagnosis. 
Widespread implementation of routine 
HIV screening and more frequent 
testing among those at greatest risk 
will be necessary to further reduce the  
percentage of people with a late stage  
HIV diagnosis. 
Data Source: National HIV Surveillance System (NHSS). See references and on-line Technical Notes for 
additional information.
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Late Stage HIV Diagnosis by Transmission Risk
•	 Late diagnosis remained fairly stable among 
most transmission risk groups from 2008 
to 2011. During this time, there was an 8% 
increase in late diagnosis among female 
injection drug users (IDUs) and an 8% 
increase among male IDUs. 
•	 More progress is needed in reducing late 
diagnoses across all transmission risk 
groups in order to achieve the 2015 goal. 
•	 The greatest improvement is needed for 
IDUs and heterosexual men. These groups 
are furthest from the 2015 goal.
Late Stage HIV Diagnosis by Age
•	 Overall, the percentage of people with a late 
stage diagnosis was fairly stable within age 
groups from 2008 to 2011. 
•	 The percentage of persons with a late 
diagnosis increases with age. 
•	 The 2015 goal had been met in all years 
among those aged 13-24 years.
•	 In order to achieve the overall 2015 goal, 
it will be especially important to decrease 




REDUCE PERINATAL HIV TRANSMISSION
Reduce the perinatal HIV transmission rate by 25%
Perinatal HIV transmission (from mother 
to child) can occur during pregnancy, 
labor and delivery, or breastfeeding. The 
perinatal HIV transmission rate measures 
the number of infants diagnosed with 
perinatally acquired HIV infections per 
100,000 live births among black/African 
American, Hispanic/Latino, and white 
mothers. It allows us to assess whether 
this type of HIV transmission is increasing 
or decreasing over time. 
From 2008 to 2010, there was a 16% 
reduction in the rate of perinatally acquired 
HIV infections; the 2010 target (6.8) was 
met. HIV testing of pregnant woman, 
effective HIV treatment for women living 
with the virus and their infants, and other 
interventions have resulted in a decline in 
the number of infants who were perinatally infected with HIV. 
Achieving the 2015 goal will require improvements in comprehensive reproductive 
health care (including HIV testing) as well as reaching and providing HIV treatment 
to HIV-infected pregnant women. In 2012, CDC developed a framework for elimi-
nating perinatal HIV transmission in the United States that, if fully implemented, 
would further reduce the annual number of perinatally acquired infections.
Perinatal HIV Transmission by Race/Ethnicity 
•	 From 2008 to 2010, perinatal transmission 
was consistently higher among black/African 
American infants than Hispanic/Latino or 
white infants. The decrease among black/
African American infants from 2009 to 
2010 is a promising sign, but substantial 
disparities remain.
•	 The 2015 goal was met in 2008, 2009 and 2010 
among white and Hispanic/Latino infants.
•	 There is a need to further reduce perinatal 
transmission, especially for black/African 
American women and their infants.
Data Source: National HIV Surveillance System (NHSS). See 
references and on-line Technical Notes for additional information.
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REDUCE SEXUAL RISK BEHAVIOR AMONG MSM
Reduce the percentage of men who have sex with men (MSM) who report unprotected anal 
intercourse with a male sex partner of discordant or unknown HIV status during their last 
sexual encounter by 25%
Unprotected anal sex is the primary 
risk for HIV infection among gay, 
bisexual, and other men who have sex 
with men (collectively referred to as 
MSM). The majority of MSM have tried 
to lower their HIV risk by not having 
or reducing unprotected anal sex or by 
only having unprotected anal sex with 
someone whose HIV status is the same 
as their own. 
Unprotected anal sex with any partner 
represents a potential risk for HIV 
transmission. Unprotected anal sex 
with a different (discordant) HIV status 
partner represents an even greater risk.
CDC collects data about sexual risk 
behaviors among MSM every three 
years in selected cities. Comparing 
2008 and 2011, there was no change in the percentage of MSM who reported 
unprotected anal sex during their last sexual encounter with a male partner 
whose HIV status was believed to be different than their own (discordant) or 
was unknown. In both years, 13.7% reported unprotected anal sex with a 
discordant or unknown HIV status partner during their last sexual encounter. 
The 2011 target of 13.5% was not met. 
A little more than half of MSM reported unprotected anal sex with one or more 
partners of any HIV status in the past 12 months. Slightly more men reported 
any unprotected anal sex in 2011 (57%) compared to 2008 (54%).
The 2015 goal was not met for any age group in 2011, and the change across years did not differ by 
age. Among racial/ethnic groups, the 2015 goal was met for Asians and Native Hawaiians/Other Pacific 
Islanders in 2011. American Indian/Alaska Native MSM were furthest from the 2015 goal. 
The lack of change in this indicator, coupled with increasing numbers of new HIV infections among MSM, 
is especially worrisome. There is an urgent need to improve the effectiveness of HIV prevention efforts 
for all MSM, especially young, racial/ethnic minority, and HIV-positive MSM. Reducing unprotected anal 
sex among MSM, especially with discordant/unknown HIV status partners, remains an important public 
health goal.
 Data Source: National HIV Behavioral Surveillance System (NHBS). See references and on-line Technical Notes for additional information.
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REDUCE SEXUAL OR INJECTION RISK 
BEHAVIOR AMONG IDUs
Reduce the percentage of injection drug users (IDUs) who report risky sexual or drug 
injection behavior during the past 12 months by 25%
The use of non-sterile injection equipment and 
risky sexual behaviors both put injection drug 
users (IDUs) at increased risk for getting or 
transmitting HIV.
CDC collects data about sexual and drug use 
behaviors among IDUs every three years in 
selected cities. For this indicator, risky sexual 
behavior is defined as unprotected vaginal or 
anal sex with a partner of the opposite sex, 
regardless of HIV status, at any time during the 
past 12 months. 
Overall, risk among IDUs was stable from 2006 
to 2009. In 2009, 74.9% of IDUs reported syringe 
sharing or unprotected sex in the previous 12 
months. About one-third (34%) reported sharing 
syringes. About two-thirds (69%) reported having unprotected vaginal sex in the previous 
12 months; 23% reported having unprotected anal sex in the previous 12 months. 
Even though risk was stable overall, it increased among Hispanic/Latino IDUs, those 
under 40 years of age, and those 60 years of age and older.
In 2009, no group had met the 2015 goal. Whites, women, and those under 40 years 
were furthest from the goal. Progress will be evaluated against the 2012 target when 
results for that year are available.
In order to achieve the 2015 goal, HIV prevention efforts for IDUs should address risky 
sexual behavior as well as syringe sharing and the use of other non-sterile injection equipment.
 Data Source: National HIV Behavioral Surveillance System (NHBS). See references and on-line Technical Notes for additional information.
19
REDUCE HIV TRANSMISSION
Reduce the HIV transmission rate by 30%
The HIV transmission rate is another 
way of assessing the impact of 
prevention, care, and treatment. It 
measures the number of new HIV 
infections in a given year per 100 people 
living with HIV. 
The HIV transmission rate is an 
important measure of progress because 
it takes into account changes in the 
number of people living with HIV.
The HIV transmission rate decreased 
about 9% from 4.6 in 2006 to 4.2 
in 2010. The 2010 target (4.6) was 
exceeded. This means that fewer 
infections are being transmitted on 
average by people living with HIV. As a 
result, the number of new HIV infections has remained stable, even though the number of 
people living with HIV increased 9% from 1,045,800 in 2006 to 1,144,500 in 2010. 
Early detection of HIV infection and comprehensive prevention with positives 
(including improved linkage and retention in high-quality HIV medical care) will be 
needed to further reduce the HIV transmission rate and achieve the 2015 goal.
Data Source: National HIV Surveillance System (NHSS). See references and on-line Technical Notes 
for additional information.
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INCREASE LINKAGE TO HIV MEDICAL CARE
Increase the percentage of persons diagnosed with HIV who are linked to HIV medical care 
within 3 months after diagnosis to 85%
Linking persons diagnosed with HIV to HIV medical 
care soon after diagnosis is essential for improving 
their health and reducing the risk of transmission 
to others. People with HIV should be linked to HIV 
medical care as soon as possible after diagnosis.
CDC monitors linkage to HIV medical care using 
laboratory data from areas with complete reporting 
of CD4 and viral load test results. People who 
had a CD4 or viral load test within 3 months after 
diagnosis are counted as being linked to HIV 
medical care. The number of areas these data are 
based on increased from 13 for 2009 to 19 for 
2011. The number of areas reporting these data is 
expected to increase in coming years, providing a 
better representation of the nation as a whole. 
Although the 2011 target (66.0%) was met, the percentage of persons diagnosed with HIV who were linked 
to HIV medical care within 3 months after diagnosis remained fairly stable at 81.7% in 2009 and 79.8% in 
2011. Results showed some movement toward the 2015 goal when the analysis was limited to the areas 
that had reported data for all 3 years. Complete reporting of laboratory data is needed in more areas to 
provide better national estimates and improve the health of people living with HIV.
In 2011, the 2015 goal had been achieved for whites and persons whose race/ethnicity was 
classified as other. In 2011, blacks/African Americans who were diagnosed with HIV were 
least likely to have been linked to HIV medical care (see pages 26-28).
Programs that conduct HIV testing should consider establishing protocols and 
implement strategies that facilitate timely linkage to HIV medical care for all people 
who are diagnosed with HIV. These strategies could include the use of laboratory and 
other surveillance data to improve linkage to care and other health outcomes among 
HIV-diagnosed persons.
Linkage to HIV Medical Care by Age
•	 Linkage to HIV medical care did not improve in 
any age group from 2009 to 2011. As of 2011, no 
group was at or above the 2015 goal. 
•	 Persons in the youngest age group (13-24 years) 
were furthest from the 2015 goal each year during 
2009 to 2011.
Data Source: National HIV Surveillance System (NHSS). See references 
and on-line Technical Notes for additional information.
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INCREASE VIRAL SUPPRESSION AMONG 
PERSONS IN HIV MEDICAL CARE
Increase the percentage of HIV-diagnosed persons in HIV medical care with a suppressed 
viral load by 10%
Reducing the level of HIV in a person’s 
body to a very low or undetectable level 
(viral suppression) is a primary goal of 
HIV treatment. A person’s viral load is 
suppressed when the results of a viral 
load test show that HIV is undetectable 
or that there are 200 or fewer copies of 
HIV per milliliter of plasma. 
Having a suppressed viral load improves 
the health of people living with HIV, 
increases survival, and reduces the 
risk of transmitting HIV. Staying in 
HIV medical care and adhering to HIV 
treatment are essential for achieving 
and maintaining a suppressed viral 
load. People who keep their medical 
appointments and take their HIV 
medication as prescribed are more likely to have a suppressed viral load than those who do not. This 
indicator is based on nationally representative data that come from the Medical Monitoring Project 
(MMP). MMP is a CDC-funded surveillance project that collects information about people with HIV who 
are receiving HIV medical care in the United States and Puerto Rico.
In 2009, about 3 of 4 people with HIV who were in HIV medical care (71.6%) had 
a suppressed viral load. No transmission risk group met the 2015 goal. Viral 
suppression was highest among gay, bisexual, and other men who have sex with 
men (collectively referred to as MSM) (75.6%), and lowest among persons who 
had injected drugs in the past 12 months (58.5%). Across racial/ethnic groups, 
the 2015 goal was met among whites only (79.5% viral suppression); non-
Hispanic blacks were furthest from the goal (64.1%). Viral suppression increased 
with age, ranging from 56.1% among 18-29 year olds to 79.3% among persons 
aged 50 years and older. The 2015 goal was met for those aged 50 years and older. 
By gender, males were closest to the 2015 goal (73.6%), followed by transgender 
persons (67.9%), and females (66.1%). 
Reducing HIV viral load has multiple benefits for people living with HIV, their partners, and 
society. Better retention in HIV medical care, early and effective HIV treatment, and greater adherence to 
HIV treatment can all contribute to increasing viral suppression among people who are in HIV medical 
care. Health care providers, health departments, community-based organizations, and people living with 
HIV all have important roles to play in increasing viral suppression.
Data Source: Medical Monitoring Project (MMP). See references and on-line Technical Notes for additional information.
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REDUCE SEXUAL RISK BEHAVIOR AMONG 
PERSONS IN HIV MEDICAL CARE
Reduce the percentage of HIV-diagnosed persons in HIV medical care who report unprotected anal or 
vaginal intercourse during the past 12 months with a partner of discordant or unknown HIV status by 33%
Unprotected anal or vaginal sex between 
someone who is living with HIV and 
an uninfected partner accounts for the 
majority of HIV infections in the United 
States. HIV treatment reduces the risk of 
HIV transmission, but viral load can vary 
over time and can be higher in some parts 
of the body than others. This means that 
all people with HIV, including those on 
treatment, may have the biological potential 
to transmit HIV during unprotected anal or 
vaginal sex with an HIV-discordant partner 
(that is, a partner whose HIV status is 
different from their own). 
In 2009, about 1 of 8 HIV-diagnosed 
persons who were in HIV medical care 
(12.9%) reported unprotected anal or 
vaginal sex in the past 12 months with a 
partner whose HIV status they did not know or knew to be discordant. 
No transmission risk group met the 2015 goal in 2009. Persons who had injected drugs in the past 12 
months (27.4%) were furthest from the 2015 goal. Including those who had injected drugs, women who 
had sex with men (14.8%) and gay, bisexual, and other men who had sex with men (collectively referred to 
as MSM) (14.0%) were furthest from the 2015 goal. Across racial/ethnic groups, non-Hispanic blacks were 
closest to the 2015 goal (10.6%), followed by Hispanics/Latinos (13.2%), and non-Hispanic whites (14.9%). 
Unprotected sex with a discordant/unknown HIV status partner decreased with age, ranging from 25.7% 
among 18-29 year olds, 20.1% among 30-39 year olds, and 12.3% among 40-49 year olds. Persons 
aged 50 years and older were least likely to report unprotected sex with a discordant/unknown HIV 
status partner (7.7%), which exceeded the overall 2015 goal. By gender, unprotected sex 
with a discordant/unknown HIV status partner was highest among transgender persons 
(18.5%), followed by females (14.4%), and males (12.2%). 
People who are diagnosed with HIV should receive a comprehensive package 
of prevention services that improves their health, reduces their risk of sexually 
transmitted infections (STIs), and reduces the risk of HIV transmission. These 
include linkage to and retention in HIV medical care, risk screening and risk-
reduction interventions, partner services, STI services, reproductive health care and 
prevention of perinatal transmission, and other medical and social services, such as 
substance use and mental health services.
Data Source: Medical Monitoring Project (MMP). See references and on-line Technical Notes for additional information.
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REDUCE HIV-RELATED DISPARITIES:  
NEW HIV INFECTIONS
Reduce the annual number of new HIV infections among men who have sex with men 
(MSM), injection drug users (IDUs), blacks/African Americans, and Hispanics/Latinos by at 
least 25% in each group
Gay, bisexual, and other men who have sex with men (collectively referred to as MSM), injection drug 
users (IDUs), blacks/African Americans, and Hispanics/Latinos are all disproportionately affected by 
HIV and are at increased risk of becoming newly infected with HIV. Achieving the nation’s 2015 goal for 
reducing HIV incidence will be heavily influenced by our ability to reduce HIV infections in these groups. 
This indicator treats MSM and MSM-IDUs as a single group—data for MSM include those who were  
also IDUs. Most of the indicators in this report treat MSM and MSM-IDUs as separate transmission  
risk groups. 
Comparing 2008 to 2010, new HIV infections decreased among IDUs but increased among MSM. New 
HIV infections increased among Hispanics/Latinos and remained stable among blacks/African Americans. 
The 2010 targets were met for IDUs and blacks/African Americans. The 2010 targets were not met for 
either MSM or Hispanics/Latinos.
Long-standing disparities represent significant challenges to preventing new HIV 
infections and achieving health equity in the United States. In order to reduce 
these disparities, cost-effective and scalable HIV prevention interventions must 
be aligned geographically and demographically with the HIV epidemic.
Data Source: National HIV Surveillance System (NHSS). See references and on-line Technical Notes for additional 
information.
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New HIV Infections among MSM
•	 In 2010, MSM represented 2% of the 
US population but accounted for 66% 
of new HIV infections (including 
MSM-IDUs).
•	 Overall, new HIV infections increased 
12% among MSM from 2008 to 2010. 
The 2010 target was not met.
•	 Because of this increase, new HIV 
infections among MSM need to 
decrease 31% from 2010 levels in order 
to achieve the 2015 goal.
New HIV Infections among IDUs  
•	 About 1 of 12 new HIV infections (8%)  
in 2010 was among males and females 
whose infection was attributed to 
injection drug use.
•	 Comparing 2008 to 2010, new HIV 
infections among IDUs decreased 
22%. The 2010 target was met. If  
new infections among IDUs stay at or 
below this level, the 2015 goal  
will be met.
•	 Among female IDUs, new infections 
decreased 29% when comparing 2008 
to 2010. Among male IDUs, new 
infections decreased 17%  
when comparing 2008 to 2010.  
[data not shown]
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New HIV Infections among Blacks/African Americans   
•	 In 2010, blacks/African Americans 
represented 12% of the US population 
but accounted for almost half (44%) of 
all new HIV infections.
•	 New HIV infections among blacks/
African Americans overall were stable. 
The 2010 target was met because there 
were fewer new infections compared to 
the 2006 baseline.
•	 Among black/African American 
females, new HIV infections  
decreased 21% from 2008 to 2010. 
[data not shown]
•	 Comparing 2008 to 2010, new infections 
increased 22% among black/African 
American males aged 13-24 years and 
decreased 9% among those aged 35 
years and older. [data not shown]
New HIV Infections among Hispanics/Latinos  
•	 Hispanics/Latinos represented 
about 16% of the US population yet 
accounted for 21% of all new HIV 
infections in 2010.
•	 Overall, new HIV infections remained 
fairly stable among Hispanics/Latinos. 
The 2010 target was not met because 
there were more new infections in that 
year compared to the 2006 baseline.
•	 Among Hispanics/Latinos, the majority 
of new HIV infections are attributable 
to male-to-male sex. New infections 
increased 19% among Hispanic/Latino 
MSM (including Hispanic/Latino 
MSM-IDUs) when comparing 2008 to 
2010 and declined among IDUs and 
heterosexuals. [data not shown]
•	 New HIV infections are higher among Hispanic/Latino males than females across all age groups. 
Comparing 2008 to 2010, the largest increase in new infections occurred among Hispanic/Latino males 
aged 13-24 years. [data not shown]
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 REDUCE HIV-RELATED DISPARITIES: 
LINKAGE TO HIV MEDICAL CARE
Increase the percentage of persons diagnosed with HIV who are linked to HIV medical care 
within 3 months after diagnosis to 85% or greater for all racial/ethnic groups
It is essential to ensure that people of all races/ethnicities get HIV medical care 
within 3 months after receiving an HIV diagnosis. This benefits their health and 
reduces the risk of onward transmission of the virus. The unique needs and 
perspectives of members of specific racial/ethnic groups must be addressed in 
order to ensure that all HIV-diagnosed individuals are linked to HIV medical care 
without delay. 
CDC monitors linkage to HIV medical care using laboratory data from areas with 
complete reporting of CD4 and viral load test results. The number of areas these data 
are based on increased from 13 for 2009 to 19 for 2011. People who had a CD4 or viral 
load test within 3 months after diagnosis are counted as being linked to HIV medical care. 
In 2011, more than 75% of HIV-diagnosed blacks/African Americans, Hispanics/Latinos, whites, and 
persons of other race/ethnicity were linked to HIV medical care within 3 months after diagnosis. The 
original 2015 goal of 75% was met or exceeded by all groups in 2011. Because of this, CDC increased  
its 2015 goal for linkage to HIV medical care to 85% for all racial/ethnic groups. This revised goal 
promotes health equity by setting the standard that all racial/ethnic groups should meet or exceed the 
overall national goal of 85% for linkage to HIV medical care. The annual targets in this report are based 
on the revised goal of 85%. Based on the revised goal, the 2011 targets were met for whites and  
persons of other race/ethnicity. The 2011 targets were not met for either blacks/African Americans or 
Hispanics/Latinos. 
Achieving the revised goal of 85% for all racial/ethnic groups will require improved coordination and 
collaboration among health care providers, health departments, and community-based organizations to 
successfully link more people with HIV, especially blacks/African Americans, to HIV medical care. 
Data Source: National HIV Surveillance System (NHSS). See references and on-line Technical Notes for additional information.
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Linkage to HIV Medical Care among Blacks/African Americans 
•	 In 2011, about 3 of 4 HIV-diagnosed 
blacks/African Americans (75.9%) 
were linked to HIV medical care 
within 3 months after diagnosis.
•	 Blacks/African Americans were the 
only racial/ethnic group in which the 
percentage linked to HIV medical 
care was less than 80% in 2011.
•	 The percentage of HIV-diagnosed 
blacks/African Americans linked to 
HIV medical care did not improve 
from 2009 to 2011. The revised 2011 
target was not met.
•	 More progress will be needed in 
order to achieve the revised 2015 
goal of 85%.
Linkage to HIV Medical Care among Hispanics/Latinos  
•	 In 2011, about 4 of 5 HIV-diagnosed 
Hispanics/Latinos (81.8%) were 
linked to HIV medical care within 3 
months after diagnosis. 
•	 The percentage of HIV-diagnosed 
Hispanics/Latinos who were linked 
to HIV medical care was fairly stable 
from 2009 to 2011. The revised 2011 
target was not met.
•	 More progress will be needed in 
order to achieve the revised 2015 
goal of 85%.
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Linkage to HIV Medical Care among Whites  
•	 In 2011, more than 4 of 5 HIV-
diagnosed whites (85.1%) were linked 
to HIV medical care within 3 months 
after diagnosis.
•	 Linkage to HIV medical care was stable 
among whites from 2009 to 2011. 
•	 In 2011, the revised 2015 goal of 85% 
had been met among whites.
Linkage to HIV Medical Care among Persons of Other Race/Ethnicity 
•	 There was a 9% overall increase in 
linkage to HIV medical care from 2009 
to 2011 among persons from other 
racial/ethnic groups.
•	 Overall, 85.9% of HIV-diagnosed 
persons from other racial/ethnic 
groups had been successfully linked to 
HIV medical care in 2011.
•	 In 2011, the percentage linked to HIV 
medical care was 90.5% for Native 
Hawaiians/Other Pacific Islanders, 
86.7% for persons of multiple races, 
85.2% for American Indian/Alaska 
Natives, and 84.6% for Asians. [data 
not shown]
•	 In 2011, the revised 2015 goal of 85% 






REDUCE HIV-RELATED DISPARITIES: VIRAL 
SUPPRESSION AMONG HIV-DIAGNOSED PERSONS
Increase the percentage of HIV-diagnosed men who have sex with men (MSM), blacks/
African Americans, and Hispanics/Latinos with a suppressed viral load by at least 20%
Increasing viral suppression among all people with HIV is an important public health goal, especially in 
communities that have the greatest burden of HIV. 
CDC monitors viral suppression among people in HIV medical care  (see page 21) and uses this 
information along with surveillance data on people living with an HIV diagnosis to estimate  viral 
suppression among all HIV-diagnosed people in the United States and Puerto Rico. This includes those 
who are in HIV medical care and those who are not. This indicator of viral suppression estimates how 
many HIV-diagnosed people have an HIV viral load that is undetectable or 200 or fewer 
copies of HIV per milliliter of plasma. Among HIV-diagnosed people, viral suppression 
can be influenced by many things including linkage to HIV medical care, retention in 
HIV medical care, and timely HIV treatment and adherence.
The overall percentage of HIV-diagnosed people with a suppressed viral load 
remained fairly stable from 2009 (37.3%) to 2010 (39.0%). 
Improvements were seen among HIV-diagnosed gay, bisexual, and other men who 
have sex with men (collectively referred to as MSM); blacks/African Americans; and 
Hispanics/Latinos. The 2010 target was met for all 3 groups. 
Although the 2010 target was met, the majority of HIV-diagnosed MSM, blacks/African 
Americans, and Hispanics/Latinos do not have suppressed viral load. Improvements in linkage to HIV medical 
care, retention, HIV treatment, and adherence can all contribute to increasing viral suppression and achieving 
the nation’s 2015 goals. 
Viral Suppression among HIV-Diagnosed MSM  
•	 Among HIV-diagnosed men whose HIV 
infection was attributed to male-to-male 
sexual contact, 40.7% had a suppressed 
viral load in 2009. 
•	 Although the 2010 target was met,  
viral suppression remained fairly stable 
from 2009 to 2010. Further improvement 
will be needed in order to achieve the 
2015 goal.
Data Source: Medical Monitoring Project (MMP) and National 
HIV Surveillance System (NHSS). See references and on-line 
Technical Notes for additional information.
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Viral Suppression among HIV-Diagnosed Blacks/African Americans 
•	 The percentage of HIV-diagnosed 
blacks/African Americans who had a 
suppressed viral load increased from 
32.7% in 2009 to 34.9% in 2010.
•	 The 2010 target was met, but 
continued improvement will be 
needed in order to achieve the  
2015 goal.
Viral Suppression among HIV-Diagnosed Hispanics/Latinos
•	 Among HIV-diagnosed Hispanics/
Latinos, 37.2% had a suppressed viral 
load in 2010. 
•	 The 2010 target was met, but 
continued improvement will be 
needed in order to achieve the  
2015 goal. 
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